Postnatal treatment using curcumin supplements to amend the damage in VPA-induced rodent models of autism
Abstract Background Valproic acid (VPA) is used as a first-line antiepileptic agent and is undergoing clinical trials for use as a treatment for many disorders. Mothers undergoing VPA treatment during early pregnancy reportedly show increased rates of autism among their offspring. The benefits of cu...
Main Authors: | Maha Al-Askar, Ramesa Shafi Bhat, Manar Selim, Laila Al-Ayadhi, Afaf El-Ansary |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | BMC Complementary and Alternative Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12906-017-1763-7 |
Similar Items
-
Analysis of variability of concentrations of valproic acid (VPA) and its selected metabolites in the blood serum of patients treated with VPA and patients hospitalized because of VPA poisoning
by: Jolanta Wilimowska, et al.
Published: (2015-03-01) -
Evaluation of Liver Enzymes Rising in Patients Treated with Sodium Valproate (VPA)
by: Javad Akhondian, et al.
Published: (2015-06-01) -
General developmental health in the VPA-rat model of autism
by: Monica Regina Favre, et al.
Published: (2013-07-01) -
Prenatal VPA exposure and changes in sensory processing by the superior colliculus
by: Georgia eDendrinos, et al.
Published: (2011-10-01) -
Differential Gene Expression Profile Induced by Valproic Acid (VPA) in Pediatric Epileptic Patients
by: Esaú Floriano-Sánchez, et al.
Published: (2018-06-01)